Trial Details
RECRUITINGBasic Information
| Clinical ID | c179 |
|---|---|
| Identifier | NCT06584162 |
| Trial Title | Subcutaneous Interval Lengthening of Vedolizumab for Economic Research |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Vedolizumab Injection |
Participant Information
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
|---|---|
| City | Amsterdam |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2023-02-09 |
|---|---|
| Primary Completion Date | 2025-01-01 |
| Completion Date | 2026-02-01 |